Literature DB >> 9371561

The ORF3 protein of hepatitis E virus is a phosphoprotein that associates with the cytoskeleton.

M Zafrullah1, M H Ozdener, S K Panda, S Jameel.   

Abstract

Hepatitis E virus (HEV) is a major human pathogen in the developing world. In the absence of an in vitro culture system, very little information exists on the basic biology of the virus. A small protein (approximately 13.5 kDa) of unknown function, pORF3, is encoded by the third open reading frame of HEV. We expressed pORF3 in transiently transfected COS-1 and Huh-7 cells and showed that it is a phosphoprotein which is modified at a serine residue(s). Deletion and site-directed mutants were created to establish Ser-80 as the phosphorylation site. This residue is present within a conserved primary sequence that showed consensus sites for phosphorylation by p34cdc2 kinase (cdc2K) and mitogen-activated protein kinase (MAPK). In vitro experiments with hexahistidine-tagged pORF3 expressed either in Escherichia coli or in COS-1 cells showed efficient phosphorylation with exogenously added MAPK. The pORF3 mutants also exhibited an in vitro phosphorylation profile with MAPK which was identical to that observed in vivo. In its primary sequence, pORF3 possesses two highly hydrophobic N-terminal domains. On subcellular fractionation, pORF3 was found to partition with the cytoskeletal fraction, and this association with the cytoskeleton was lost on deletion of hydrophobic domain I (amino acid residues 1 to 32). These results suggest that HEV pORF3 is a cytoskeleton-associated phosphoprotein and are discussed in terms of a possible function for pORF3 within the HEV replicative cycle.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9371561      PMCID: PMC230205     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

Review 1.  Chemical inhibitors of cyclin-dependent kinases.

Authors:  L Meijer
Journal:  Prog Cell Cycle Res       Date:  1995

2.  Mutagenesis of the conserved 51-nucleotide region of Sindbis virus.

Authors:  H G Niesters; J H Strauss
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

3.  Activation of multiple protein kinases during the burst in protein phosphorylation that precedes the first meiotic cell division in Xenopus oocytes.

Authors:  M F Cicirelli; S L Pelech; E G Krebs
Journal:  J Biol Chem       Date:  1988-02-05       Impact factor: 5.157

Review 4.  Enterically-transmitted non-A, non-B hepatitis.

Authors:  D W Bradley
Journal:  Br Med Bull       Date:  1990-04       Impact factor: 4.291

5.  Definition of a consensus sequence for peptide substrate recognition by p44mpk, the meiosis-activated myelin basic protein kinase.

Authors:  I Clark-Lewis; J S Sanghera; S L Pelech
Journal:  J Biol Chem       Date:  1991-08-15       Impact factor: 5.157

6.  Rapid stimulation by insulin of a serine/threonine kinase in 3T3-L1 adipocytes that phosphorylates microtubule-associated protein 2 in vitro.

Authors:  L B Ray; T W Sturgill
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

7.  Incidence and severity of viral hepatitis in pregnancy.

Authors:  M S Khuroo; M R Teli; S Skidmore; M A Sofi; M I Khuroo
Journal:  Am J Med       Date:  1981-02       Impact factor: 4.965

8.  Activation of a Ca2+-inhibitable protein kinase that phosphorylates microtubule-associated protein 2 in vitro by growth factors, phorbol esters, and serum in quiescent cultured human fibroblasts.

Authors:  M Hoshi; E Nishida; H Sakai
Journal:  J Biol Chem       Date:  1988-04-15       Impact factor: 5.157

9.  Study of an epidemic of non-A, non-B hepatitis. Possibility of another human hepatitis virus distinct from post-transfusion non-A, non-B type.

Authors:  M S Khuroo
Journal:  Am J Med       Date:  1980-06       Impact factor: 4.965

10.  Identification of the regulatory phosphorylation sites in pp42/mitogen-activated protein kinase (MAP kinase).

Authors:  D M Payne; A J Rossomando; P Martino; A K Erickson; J H Her; J Shabanowitz; D F Hunt; M J Weber; T W Sturgill
Journal:  EMBO J       Date:  1991-04       Impact factor: 11.598

View more
  92 in total

1.  Detection of immunoglobulin M antibodies to hepatitis E virus by class capture enzyme immunoassay.

Authors:  C Yu; R E Engle; J P Bryan; S U Emerson; R H Purcell
Journal:  Clin Diagn Lab Immunol       Date:  2003-07

2.  The hepatitis E virus open reading frame 3 protein activates ERK through binding and inhibition of the MAPK phosphatase.

Authors:  Anindita Kar-Roy; Hasan Korkaya; Ruchi Oberoi; Sunil Kumar Lal; Shahid Jameel
Journal:  J Biol Chem       Date:  2004-04-19       Impact factor: 5.157

3.  Evidence of recombination between divergent hepatitis E viruses.

Authors:  Hélène van Cuyck; Jun Fan; David L Robertson; Pierre Roques
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

4.  ORF3 protein of hepatitis E virus is not required for replication, virion assembly, or infection of hepatoma cells in vitro.

Authors:  Suzanne U Emerson; Hanh Nguyen; Udana Torian; Robert H Purcell
Journal:  J Virol       Date:  2006-08-23       Impact factor: 5.103

5.  In vitro and in vivo mutational analysis of the 3'-terminal regions of hepatitis e virus genomes and replicons.

Authors:  Judith Graff; Hanh Nguyen; Chaiyan Kasorndorkbua; Patrick G Halbur; Marisa St Claire; Robert H Purcell; Suzanne U Emerson
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

6.  Cross-species infection of pigs with a novel rabbit, but not rat, strain of hepatitis E virus isolated in the United States.

Authors:  Caitlin M Cossaboom; Laura Córdoba; Brenton J Sanford; Pablo Piñeyro; Scott P Kenney; Barbara A Dryman; Youchun Wang; Xiang-Jin Meng
Journal:  J Gen Virol       Date:  2012-04-25       Impact factor: 3.891

7.  Borna disease virus nucleoprotein interacts with the CDC2-cyclin B1 complex.

Authors:  Oliver Planz; Stephan Pleschka; Katja Oesterle; Friederike Berberich-Siebelt; Christina Ehrhardt; Lothar Stitz; Stephan Ludwig
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

8.  Hepatitis E Virus Genotype 3 Genomes from RNA-Positive but Serologically Negative Plasma Donors Have CUG as the Start Codon for ORF3.

Authors:  Heléne Norder; Cristina Galli; Ellen Magnil; Per Sikora; Elisabet Ekvärn; Kristina Nyström; Lars O Magnius
Journal:  Intervirology       Date:  2018-10-02       Impact factor: 1.763

Review 9.  Hepatitis E: an overview and recent advances in vaccine research.

Authors:  Ling Wang; Hui Zhuang
Journal:  World J Gastroenterol       Date:  2004-08-01       Impact factor: 5.742

10.  In vitro replication of hepatitis E virus (HEV) genomes and of an HEV replicon expressing green fluorescent protein.

Authors:  Suzanne U Emerson; Hanh Nguyen; Judith Graff; David A Stephany; Alicia Brockington; Robert H Purcell
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.